Azathioprine-induced hypersensitivity hepatitis: Tolerance to 6-mercaptopurine

Inflammatory Bowel Diseases

Volumn 16, Issue 11, 2010, Pages 1828-1829

  Andrejic, Jelena ^a   Rojas Balcazar, Juan ^a   Dennis, Madison ^a   Berkelhammer, Charles ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; DRUG METABOLITE; MERCAPTOPURINE; MESALAZINE; METHYLMERCAPTOPURINE; PREDNISONE; THIOPURINE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; DESENSITIZATION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG ERYTHROCYTE LEVEL; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEPATITIS; HUMAN; HYPERSENSITIVITY HEPATITIS; LETTER; LIVER FUNCTION TEST; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; ACUTE DISEASE; AZATHIOPRINE; COLITIS, ULCERATIVE; DRUG HYPERSENSITIVITY; DRUG-INDUCED LIVER INJURY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MESALAMINE; METHYLTRANSFERASES; MIDDLE AGED; PREDNISOLONE; TREATMENT OUTCOME;

EID: 78249284642     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21240     Document Type: Letter

References (9)

1. Gisbert JP, González-Lama Y, Maté J,. Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review. Am J Gastroenterol. 2007; 102: 1518-1527.
2. Gisbert JP, Luna M, González-Lama Y, et al. Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients. Inflamm Bowel Dis. 2007; 13: 1106-1114.
3. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000; 118: 705-713.
4. Shaye OA, Yadegari M, Abreu MT, Poordad F, et al. Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD patients. Am J Gastroenterol. 2007; 102: 2488-2494.
5. McGovern DP, Travis SP, Duley J, et al. Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity. Gastroenterology. 2002; 122: 838-839.
6. Kiefer K, El-Matary W,. 6-Mercaptopurine as an alternative to azathioprine in azathioprine-induced hepatoxicity. Inflamm Bowel Dis. 2009; 15: 318-319.
7. Hindorf U, Johansson M, Eriksson A, et al. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2009; 29: 654-661.
8. Gearry RB, Barclay ML, Burt MJ, et al. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease. Pharmacoepidemiol Drug Saf. 2004; 13: 563-567.
9. Lees CW, Maan AK, Hansoti B, et al. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008; 27: 220-227.